Skip to main content

What the FDA labels say about taking them together

Carbamazepine and fesoterodine

Fesoterodine's FDA label of April 7, 2026 names carbamazepine in its drug interactions section; the carbamazepine labels PlainMeds reads (3) do not name fesoterodine. The fesoterodine label: “No dosing adjustments are recommended in the presence of CYP3A4 inducers, such as rifampin and carbamazepine.”

Check it at the source: the carbamazepine FDA label on DailyMed (effective August 20, 2026, Novartis Pharmaceuticals Corporation); the fesoterodine FDA label on DailyMed (effective April 7, 2026, Pfizer Laboratories Div Pfizer Inc).

What does the carbamazepine label say about fesoterodine?

Carbamazepine's label (effective August 20, 2026) and its 2 other brand-application labels do not name fesoterodine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Tegretol), Novartis Pharmaceuticals Corporation, effective August 20, 2026 (SPL set 8d409411-aa9f-4f3a-a52c-fbcb0c3ec053), via openFDA; the full label on DailyMed

What does the fesoterodine label say about carbamazepine?

Fesoterodine label, drug interactions

No dosing adjustments are recommended in the presence of CYP3A4 inducers, such as rifampin and carbamazepine.

Source: FDA drug label (Toviaz), Pfizer Laboratories Div Pfizer Inc, effective April 7, 2026 (SPL set 5be745f0-8ae7-4c3c-9962-37d6263326f1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

42Carbamazepine generic labelers
11Fesoterodine generic labelers
CarbamazepineFesoterodine
Labeled forBipolar disorder, Seizures and epilepsyOveractive bladder
Boxed warningYesNo
Pharmacy cost (NADAC)$0.119 per tablet 200 mg tablet$0.794 per tablet 4 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?